Comparative Cost-effectiveness of Surgery, Collagenase Clostridium Histolyticum, and Penile Traction Therapy in Men with Peyronie's Disease in an Era of Effective Clinical Treatment.

[1]  L. Trost,et al.  Outcomes of a Novel Penile Traction Device in Men with Peyronie's Disease: A Randomized, Single-Blind, Controlled Trial. , 2019, The Journal of urology.

[2]  I. Goldstein.  111 Long-term Safety and Curvature Deformity Characterization in Patients Previously Treated with Collagenase Clostridium Histolyticum for Peyronie’s Disease , 2019, Journal of Sexual Medicine.

[3]  H. Porst,et al.  Penile traction therapy with the new device ‘Penimaster PRO’ is effective and safe in the stable phase of Peyronie's disease: a controlled multicentre study , 2018, BJU international.

[4]  K. Wymer,et al.  Plaque Calcification: An Important Predictor of Collagenase Clostridium Histolyticum Treatment Outcomes for Men With Peyronie's Disease. , 2018, Urology.

[5]  L. Trost,et al.  LBA8 PRELIMINARY OUTCOMES OF A NOVEL PENILE TRACTION DEVICE (RESTOREX) IN MEN WITH PEYRONIE’S DISEASE: A RANDOMIZED, CONTROLLED TRIAL , 2018 .

[6]  L. Trost,et al.  Conservatively Managed Peyronie's Disease-Long-term Survey Results From Patients Undergoing Nonsurgical and Noninjection Therapies. , 2017, Urology.

[7]  L. Trost,et al.  Clinical Experience With Penile Traction Therapy Among Men Undergoing Collagenase Clostridium histolyticum for Peyronie Disease. , 2017, Urology.

[8]  Y. Lotan,et al.  Superior Cost Effectiveness of Penile Plication vs Intralesional Collagenase Injection for Treatment of Peyronie's Disease Deformities , 2016, Urology practice.

[9]  L. Trost,et al.  Restoration of Penile Function and Patient Satisfaction with Intralesional Collagenase Clostridium Histolyticum Injection for Peyronie's Disease. , 2016, The Journal of urology.

[10]  G. Hatzichristodoulou.  Grafting techniques for Peyronie’s disease , 2016, Translational andrology and urology.

[11]  I. Goldstein,et al.  Clinical efficacy of collagenase Clostridium histolyticum in the treatment of Peyronie's disease by subgroup: results from two large, double‐blind, randomized, placebo‐controlled, phase III studies , 2015, BJU international.

[12]  M. Pinsky,et al.  The Effect of Duration of Penile Traction Therapy in Patients Undergoing Intralesional Injection Therapy for Peyronie's Disease. , 2015, The Journal of urology.

[13]  K. Coyne,et al.  Self-report and Clinical Response to Peyronie's Disease Treatment: Peyronie's Disease Questionnaire Results From 2 Large Double-Blind, Randomized, Placebo-Controlled Phase 3 Studies. , 2015, Urology.

[14]  E. Costantini,et al.  Corporoplasty using buccal mucosa graft in Peyronie disease: is it a first choice? , 2015, Urology.

[15]  Joshua T. Cohen,et al.  Updating cost-effectiveness--the curious resilience of the $50,000-per-QALY threshold. , 2014, The New England journal of medicine.

[16]  J. Carballido,et al.  Acute phase Peyronie's disease management with traction device: a nonrandomized prospective controlled trial with ultrasound correlation. , 2014, The journal of sexual medicine.

[17]  I. Goldstein,et al.  Clinical efficacy, safety and tolerability of collagenase clostridium histolyticum for the treatment of peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies. , 2013, The Journal of urology.

[18]  C. Roehrborn,et al.  Reduction in hospital admission rates due to post-prostate biopsy infections after augmenting standard antibiotic prophylaxis. , 2013, The Journal of urology.

[19]  A. Salonia,et al.  EAU guidelines on penile curvature. , 2012, European urology.

[20]  S. Minareci,et al.  Erectile dysfunction after plaque incision and grafting: short-term assessment of incidence and predictors. , 2012, The journal of sexual medicine.

[21]  L. Lipshultz,et al.  Phase 2b study of the clinical efficacy and safety of collagenase Clostridium histolyticum in patients with Peyronie disease. , 2012, The Journal of urology.

[22]  T. Graziottin,et al.  Long-term follow-up of penile curvature correction utilizing autologous albugineal crural graft. , 2012, International braz j urol : official journal of the Brazilian Society of Urology.

[23]  Eric Chung,et al.  Five-year follow-up of Peyronie's graft surgery: outcomes and patient satisfaction. , 2011, The journal of sexual medicine.

[24]  S. Perovic,et al.  The management of Peyronie's disease: evidence-based 2010 guidelines. , 2010, The journal of sexual medicine.

[25]  A. Tizzani,et al.  Use of penile extender device in the treatment of penile curvature as a result of Peyronie's disease. Results of a phase II prospective study. , 2009, The journal of sexual medicine.

[26]  L. Levine,et al.  Penile traction therapy for treatment of Peyronie's disease: a single-center pilot study. , 2008, The journal of sexual medicine.

[27]  H. Eid,et al.  The prevalence of Peyronie's disease in diabetic patients with erectile dysfunction , 2007, International Journal of Impotence Research.

[28]  Susan T. Stewart,et al.  Utilities For Prostate Cancer Health States in Men Aged 60 and Older , 2005, Medical care.

[29]  W. Hellstrom,et al.  Critical analysis of surgery for Peyronie's disease , 2004, Current opinion in urology.

[30]  John Dean,et al.  Summary of the recommendations on sexual dysfunctions in men. , 2004, The journal of sexual medicine.

[31]  L. Brown,et al.  Interval Estimation for a Binomial Proportion , 2001 .

[32]  Michael E. Chernew,et al.  Willingness to Pay for a Quality-adjusted Life Year , 2000, Medical decision making : an international journal of the Society for Medical Decision Making.

[33]  Andrew H. Briggs,et al.  Handling Uncertainty in Cost-Effectiveness Models , 2000, PharmacoEconomics.

[34]  F. Rutten,et al.  Cost utility analysis of sildenafil compared with papaverine-phentolamine injections , 2000, BMJ : British Medical Journal.

[35]  L. Trost,et al.  MP65-18 PRELIMINARY OUTCOMES OF A NOVEL PENILE TRACTION DEVICE (RESTOREX) IN MEN WITH PEYRONIE’S DISEASE: A RANDOMIZED, CONTROLLED TRIAL , 2019, Journal of Urology.

[36]  L. Levine,et al.  Combination of penile traction, intralesional verapamil, and oral therapies for Peyronie's disease. , 2012, The journal of sexual medicine.

[37]  W. Hellstrom,et al.  Implants, mechanical devices, and vascular surgery for erectile dysfunction. , 2010, The journal of sexual medicine.

[38]  J. Mulhall,et al.  ORIGINAL RESEARCH—SURGERY: A Surgical Algorithm for Men with Combined Peyronie's Disease and Erectile Dysfunction: Functional and Satisfaction Outcomes , 2005 .

[39]  H A Feldman,et al.  Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. , 1994, The Journal of urology.

[40]  J. V. Vande Berg,et al.  Mechanisms of calcification in Peyronie's disease. , 1982, The Journal of urology.